HS
HighVista Strategies Portfolio holdings
AUM
$272M
1-Year Return
24.34%
This Quarter Return
+5.82%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$123M
AUM Growth
-$45.7M
(-27%)
Cap. Flow
-$43.1M
Cap. Flow
% of AUM
-35.11%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
142
New
37
Increased
19
Reduced
19
Closed
34
Top Buys
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
$3.46M |
| 2 |
Albertsons Companies
ACI
|
$3.2M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$3.17M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.14M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$2.61M |
Top Sells
| 1 |
Dell
DELL
|
$14.3M |
| 2 |
Mastercard
MA
|
$12.9M |
| 3 |
Fiserv
FI
|
$9.07M |
| 4 |
Visa
V
|
$8.83M |
| 5 |
MSDAU
MSD Acquisition Corp. Unit
MSDAU
|
$5.05M |
Sector Composition
| 1 | Healthcare | 67.14% |
| 2 | Technology | 10.92% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Financials | 4.39% |
| 5 | Communication Services | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Terns Pharmaceuticals
TERN
$602M
| $1.74M | 1.42% |
146,854
+69,510
| +90% | +$823K |
|
27
Arcellx
ACLX
$3.93B
| $1.67M | 1.36% |
+54,280
| New | +$1.67M |
|
28
Repare Therapeutics
RPTX
$71.7M
| $1.62M | 1.32% |
164,890
| – | – |
|
29
Aclaris Therapeutics
ACRS
$220M
| $1.6M | 1.3% |
197,803
+10,184
| +5% | +$82.4K |
|
30
Dyne Therapeutics
DYN
$1.86B
| $1.18M | 0.96% |
102,431
| – | – |
|
|
KDNY
31
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.15M | 0.93% |
49,495
| – | – |
|
32
Salesforce
CRM
$233B
| $1.12M | 0.91% |
5,610
+3,340
| +147% | +$667K |
|
33
Sarepta Therapeutics
SRPT
$1.93B
| $1.06M | 0.87% |
7,713
| – | – |
|
34
Microsoft
MSFT
$3.77T
| $1.05M | 0.85% |
3,640
+120
| +3% | +$34.6K |
|
35
Acadia Pharmaceuticals
ACAD
$4.31B
| $1.05M | 0.85% |
55,574
-1,044
| -2% | -$19.6K |
|
36
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $1.01M | 0.82% |
42,396
| – | – |
|
|
VRNA
37
Verona Pharma
VRNA
$9.18B
| $958K | 0.78% |
47,723
-20,968
| -31% | -$421K |
|
38
BioMarin Pharmaceuticals
BMRN
$10.9B
| $943K | 0.77% |
9,701
| – | – |
|
39
Xenon Pharmaceuticals
XENE
$2.96B
| $907K | 0.74% |
25,340
| – | – |
|
40
Pliant Therapeutics
PLRX
$98.8M
| $905K | 0.74% |
34,035
-7,427
| -18% | -$198K |
|
41
Celldex Therapeutics
CLDX
$1.5B
| $890K | 0.73% |
24,742
| – | – |
|
42
Krystal Biotech
KRYS
$4.3B
| $885K | 0.72% |
11,058
| – | – |
|
43
Alphabet (Google) Class C
GOOG
$2.78T
| $884K | 0.72% |
8,500
+2,530
| +42% | +$263K |
|
44
argenx
ARGX
$44.8B
| $869K | 0.71% |
2,333
| – | – |
|
45
Amicus Therapeutics
FOLD
$2.44B
| $857K | 0.7% |
77,314
| – | – |
|
46
Merus
MRUS
$4.93B
| $846K | 0.69% |
+45,957
| New | +$846K |
|
47
Alnylam Pharmaceuticals
ALNY
$59.7B
| $812K | 0.66% |
4,056
| – | – |
|
48
PTC Therapeutics
PTCT
$4.5B
| $801K | 0.65% |
+16,535
| New | +$801K |
|
49
Ventyx Biosciences
VTYX
$183M
| $790K | 0.64% |
23,583
-9,673
| -29% | -$324K |
|
50
Ascendis Pharma
ASND
$12.1B
| $787K | 0.64% |
7,338
| – | – |
|